Risk of MS Relapse Not Increased by COVID-19 Vaccine, Study Finds

Risk of MS Relapse Not Increased by COVID-19 Vaccine, Study Finds

305233

Risk of MS Relapse Not Increased by COVID-19 Vaccine, Study Finds

Getting the Pfizer-BioNTech vaccine for COVID-19 does not increase the risk of multiple sclerosis (MS) relapses in the two months following vaccination, according to a new study. The results support recommending COVID-19 vaccines for people with MS, its researchers said. “The incidence of relapses in the 2 months before and after vaccination was not statistically different,” the investigators wrote. The study, “mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis,”…

You must be logged in to read/download the full post.